Surfactant protein A inhibits lipopolysaccharide-induced immune cell activation by preventing the interaction of lipopolysaccharide with lipopolysaccharide-binding protein

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 3, 2002, Pages 353-360

  Stamme, Cordula ^a   Müller, Mareike ^a   Hamann, Lutz ^a   Gutsmann, Thomas ^a   Seydel, Ulrich ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0036731527     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4812     Document Type: Article

References (49)

1. The molecular pathogenesis of endotoxic shock and organ failure
2. Chemical structure, molecular conformation and bioreactivity of endotoxins
3. Bacterial lipopolysaccharides and innate immunity
4. LPS induction of gene expression in human monocytes
5. Isolation of a lipopolysaccharide -binding acute phase reactant from rabbit serum
6. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein
7. Binding of bacterial peptidoglycan to CD14
8. Tlr4: Central component of the sole mammalian LPS sensor
9. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4
10. New insights into endotoxin-induced activation of macrophages: Involvement of a K+ channel in transmembrane signaling
11. Surfactant proteins A and D and pulmonary host defense
12. Surfactant protein A (SP-A) gene targeted mice
13. Immunomodulatory functions of surfactant
14. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection
15. Surfactant protein A-deficient mice are susceptible to Pseudomonas aeruginosa infection
16. Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions
17. Surfacrant protein A protects growing cells and reduces TNF-α activity from LPS-stimulated macrophages
18. Surfactant protein A activates NF-kappa B in the THP-1 monocytic cell line
19. Induction of TNF-α release from human buffy coat cells by Pseudomonas aeruginosa is reduced by lung surfactant protein A
20. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14
21. Surfactant protein A differentially regulates IFN-γ and LPS-induced nitrite production by rat alveolar macrophages
22. Effect of surfactant protein A (SP-A) on the production of cytokines by human pulmonary macrophages
23. Interaction of surfactant protein A with lipopolysaccharide and regulation of inflammatory cytokines in the THP-1 monocytic cell line
24. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo
25. Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides
26. Surfactant proteins A and D bind CD14 by different mechanisms
27. Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide
28. Production of the acute-phase protein lipopolysaccharide -binding protein by respiratory type II epithelial cells
29. Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome
30. Recognition of bacterial endotoxin in the lungs
31. A new method for the extraction of R lipopolysaccharides
32. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity
33. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells
34. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells
35. Surfactant protein A enhances the binding and deacylation of E. coli LPS by alveolar macrophages
36. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway
37. Biospecific interaction analysis using biosensor technology
38. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes
39. Surfactant protein a inhibits peptidoglycan-induced TNF-α secretion in U937 cells and alveolar macrophages by direct interaction with Toll-like receptor 2
40. Surfactant protein A down-regulates proinflammatory cytokine production evoced by Candida albicans in human alveolar macrophages and monocytes
41. Surfactant protein A stimulation of inflammatory cytokines and immunglobulin production
42. Serial changes in surfactant-associated proteins in lung before and after onset of ARDS
43. Asthma and endotoxin: Lipopolysaccharide-binding protein and soluble CD14 in bronchoalveolar compartment
44. Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide
45. LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction
46. Acute-phase proteins and other systemic responses to inflammation
47. Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages
48. Pulmonary surfactant protein A (SP-A) is expressed by epithelial cells of small and large intestine
49. Localization and functions of Sp-A and SP-D at mucosal surfaces